Cargando…
Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial
SARS-CoV-2 and its different variants caused a “wave and wave” pandemic pattern. During the first wave we demonstrated that standardized Brazilian green propolis extract (EPP-AF®) reduces length of hospital stay in adult patients with COVID-19. Afterwards, we decided to evaluate the impact of EPP-AF...
Ejemplares similares
-
The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial
por: Silveira, Marcelo Augusto Duarte, et al.
Publicado: (2022) -
The Inhibition of Inflammasome by Brazilian Propolis (EPP-AF)
por: Hori, Juliana I., et al.
Publicado: (2013) -
Effects of Standardized Brazilian Green Propolis Extract (EPP-AF®) on Inflammation in Haemodialysis Patients: A Clinical Trial
por: Duarte Silveira, Marcelo Augusto, et al.
Publicado: (2022) -
Antimicrobial Brazilian Propolis (EPP-AF) Containing Biocellulose Membranes as Promising Biomaterial for Skin Wound Healing
por: Barud, Hernane da Silva, et al.
Publicado: (2013) -
Propolis Standardized Extract (EPP-AF®), an Innovative Chemically and Biologically Reproducible Pharmaceutical Compound for Treating Wounds
por: Berretta, Andresa Aparecida, et al.
Publicado: (2012)